EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Increased risk of osteoporotic fractures and osteoporosis in patients with Addison's disease in Sweden: A nationwide population‐based cohort study

Stavros Stergianos iD, Tim Spelman, Daniel Eriksson iD, Sara Öster, Sigridur Björnsdottir, Olle Kämpe iD, Jakob Skov iD, Sophie Bensing

Journal of Internal Medicine · 2025

DOI: 10.1111/joim.20085 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Internal Medicine, 2025. Verfasst von Stavros Stergianos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Addison Disease, Osteoporotic Fractures, Osteoporosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Knut and Alice Wallenberg Foundation, Torsten and Ragnar Söderberg Foundations, Novo Nordisk Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The risk of major osteoporotic fractures (MOFs) and osteoporosis in patients with autoimmune Addison's disease (AAD) is unclear.

Objective

To investigate the risk of MOF in patients with AAD and the possible correlation with adrenal hormone replacement doses.

Methods

Swedish national health registers were used to identify 1869 subjects with AAD and 16,844 matched controls. The primary outcome was MOF, and the secondary outcome was treatment with osteoporosis medications. Marginal Cox models were used to compare time‐to‐event outcomes. The study period spanned from 1 July 2005 until 31 December 2020. Individuals at risk were followed from inclusion until censored or the end of the study period.

Results

A total of 77 patients with AAD (7.1/1000 person‐years [PY]), and 387 matched controls (3.9/1000 PY) were diagnosed with MOF. The risk of MOF was higher in patients with AAD compared to matched controls, with an adjusted hazard ratio (aHR) of 1.82 (95% confidence interval [CI], 1.41–2.35) and increased in both male and female patients, with aHR of 2.51 (95% CI, 1.56–4.02) and 1.65 (95% CI, 1.22–2.24), respectively. Patients with AAD had an increased risk of treatment with osteoporosis medications: aHR 3.25 (95% CI, 2.71–3.99), compared to controls. No significant differences in MOF rates were observed between patients treated with intermediate or high doses of glucocorticoids compared to low doses ( p = 0.967 and p = 0.580, respectively). Similarly, stratification by mineralocorticoid dose (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Addison DiseaseOsteoporotic FracturesOsteoporosisHumansFemaleMaleSwedenMiddle AgedAgedAdultRisk FactorsCohort StudiesRegistriesGlucocorticoidsCase-Control Studies

Stichwörter der Autor:innen

Addison's diseaseadrenal insufficiencyfracturesglucocorticoidsmineralocorticoidsosteoporosis

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Department of Medicine (Solna), Center for Molecular Medicine, Karolinska Institutet, Sweden.
  • Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Department of Medicine, Karlstad Central Hospital, Karlstad, Sweden.

ORCID-Profile: Stavros Stergianos, Daniel Eriksson, Olle Kämpe, Jakob Skov

Förderung

  • Knut and Alice Wallenberg Foundation
  • Torsten and Ragnar Söderberg Foundations
  • Novo Nordisk Foundation
  • Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and Karolinska Institutet
  • Swedish Research Council
  • Värmland's County Research Council
  • Knut och Alice Wallenbergs Stiftelse
  • Novo Nordisk Fonden

Zitieren

APA

Stergianos, S., Spelman, T., Eriksson, D., Öster, S., Björnsdottir, S., Kämpe, O., Skov, J., & Bensing, S. (2025). Increased risk of osteoporotic fractures and osteoporosis in patients with Addison's disease in Sweden: A nationwide population‐based cohort study. Journal of Internal Medicine. https://doi.org/10.1111/joim.20085

Vancouver

Stergianos S, Spelman T, Eriksson D, Öster S, Björnsdottir S, Kämpe O, et al. Increased risk of osteoporotic fractures and osteoporosis in patients with Addison's disease in Sweden: A nationwide population‐based cohort study. Journal of Internal Medicine. 2025. doi:10.1111/joim.20085

BibTeX
@article{Stergianos2025,
  author = {Stergianos, Stavros and Spelman, Tim and Eriksson, Daniel and Öster, Sara and Björnsdottir, Sigridur and Kämpe, Olle and Skov, Jakob and Bensing, Sophie},
  title = {Increased risk of osteoporotic fractures and osteoporosis in patients with Addison's disease in Sweden: A nationwide population‐based cohort study},
  journal = {Journal of Internal Medicine},
  year = {2025},
  doi = {10.1111/joim.20085}
}
Kostenlos starten →